HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease.

Abstract
A dysfunction of glutamate signaling is implicated at several levels in the pathogenesis of Alzheimer's disease. Currently, metabotropic glutamate receptors, which have a wide distribution in the central nervous system and activate a multitude of cell signaling pathways, are pursued as targets for therapeutic intervention in Alzheimer's disease. Research is still limited, but results underscore the relevance of ongoing studies. Here we discuss the latest updates regarding metabotropic glutamate receptors and their role in Alzheimer's disease, as well as promising metabotropic glutamate receptor ligands that have been investigated in preclinical models of Alzheimer's disease.
AuthorsFilippo Caraci, Ferdinando Nicoletti, Agata Copani
JournalCurrent opinion in pharmacology (Curr Opin Pharmacol) Vol. 38 Pg. 1-7 (02 2018) ISSN: 1471-4973 [Electronic] England
PMID29278824 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2017 Elsevier Ltd. All rights reserved.
Chemical References
  • Receptors, Metabotropic Glutamate
Topics
  • Alzheimer Disease (drug therapy, metabolism)
  • Animals
  • Brain (metabolism)
  • Humans
  • Receptors, Metabotropic Glutamate (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: